Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cogrx

Cogrx
2007 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.06M LATEST DEAL AMOUNT
29 INVESTORS
Description

Developer of small molecule therapeutics designed to offer treatment of toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other neuro-degenerative diseases of the human brain. The company's uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system, enabling patients to recover faster through advanced medical technology.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2403 Sidney Street
  • Pittsburgh, PA 15203
  • United States

+1 (412) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cogrx’s full profile, request a free trial.

Cogrx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 27-Nov-2018 $4.06M 000.00 Completed Clinical Trials - General
12. Grant 02-Oct-2018 000.00 000.00 Completed Clinical Trials - General
11. Later Stage VC (Series B) 30-Nov-2016 00.000 000.00 000.00 Completed Clinical Trials - General
10. Grant 29-Sep-2016 000.00 Completed Clinical Trials - General
9. Later Stage VC (Series B) 01-Aug-2015 00.000 000.00 000.00 Completed Clinical Trials - General
8. Later Stage VC (Series B) 01-Jun-2014 0000 000.00 0000 Completed Clinical Trials - General
7. Later Stage VC 28-Jun-2013 00000 000.00 Completed Clinical Trials - General
6. Early Stage VC (Series A2) 01-May-2012 000 000.00 0000 Completed Clinical Trials - General
5. Early Stage VC 01-Jan-2011 $2.5M $7.22M Completed Clinical Trials - General
4. Early Stage VC (Series A1) 01-Dec-2010 $2.1M $4.72M 00.000 Completed Clinical Trials - General
To view this company’s complete deal history including valuation and funding, request access »

Cogrx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 3,970,776 $0.001000 8% $0.69 $0.69 1x $0.69 9.86%
Series A 3,067,519 $0.001000 8% $0.69 $0.69 1x $0.69 7.62%
To view this company’s complete Cap Table, request access »

Cogrx Competitors (63)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rodin Therapeutics Formerly VC-backed Cambridge, MA 000.00 000000&0 000.00
000000 00000000000 Venture Capital-Backed South San Francisco, CA 00 00000 000000000 00000
0000000 0000000000 Venture Capital-Backed La Jolla, CA 00000 00000000000 00000
0000000000 Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 0000000000 00000
To view this company’s complete list of competitors, request access »

Cogrx Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Audrey's Kitchen Family Office 000 0000 000000 0
Next Act Fund Angel Group 000 0000 000000 0
National Institute On Aging Government 000 0000 000000 0
Steelhead Capital Management Family Office Minority 000 0000 000000 0
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
You’re viewing 5 of 29 investors. Get the full list »

Cogrx Executive Team (7)

Name Title Board
Seat
Contact
Info
Kenneth Moch President, Chief Executive Officer & Board Member
Susan Catalano Ph.D Co-Founder, Chief Scientific Officer & Board Member
Harold Safferstein Ph.D Senior Vice President, Corporate Development
Michael Grundman MD Chief Medical Officer
Stephen DiPalma Chief Financial Officer

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

Cogrx Board Members (12)

Name Representing Role Since Contact
Info
Aaron Fletcher Ph.D Bios Partners Board Member 000 0000
Irwin Scher MD Self Board Member 000 0000
Kenneth Moch Cogrx President, Chief Executive Officer & Board Member 000 0000
Mark Breedlove Self Board Member 000 0000
Peggy Wallace Golden Seeds Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »